(Q40939190)

25 September 2017

1 reference

title

Second-generation adenovirus vectors (English)

1 reference

25 September 2017

1 reference

Wang Q

1

1 reference

PubMed ID

8640568

25 September 2017

Finer MH

series ordinal

2

1 reference

PubMed ID

8640568

25 September 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

25 September 2017

1 reference

25 September 2017

2

1 reference

25 September 2017

714-716

1 reference

25 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0696-714

25 September 2017

0 references

cites work

Gene therapy: adenovirus vectors.

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

Developmental control of a promoter-specific factor that is also regulated by the E1A gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

Interaction of adenoviral E4 and E1b products in late gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

Correction of a deletion mutant by gene targeting with an adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

Further Subgrouping of the Human Adenoviruses by Differential Hemagglutination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

Gene transfer into mammalian somatic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Antigens and structure of the adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Complementation of adenovirus E4 mutants by transient expression of E4 cDNA and deletion plasmids

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Characterization of mouse inhibin alpha gene and its promoter

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Virus-Receptor Interaction in an Adenovirus System

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and beta-galactosidase

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

1 reference

https://api.crossref.org/works/10.1038%2FNM0696-714

7 January 2021

Identifiers

DOI

10.1038/NM0696-714

1 reference

25 September 2017

1 reference

PubMed ID

8640568